282 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Wall Street Analysts See Canoo (GOEV) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2252543/wall-street-analysts-see-canoo-goev-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2252543 Apr 09, 2024 - Based on the average brokerage recommendation (ABR), Canoo (GOEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Wall Street Analysts See a 218.92% Upside in Annovis Bio (ANVS): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2251973/wall-street-analysts-see-a-218-92-upside-in-annovis-bio-anvs-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2251973 Apr 08, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 218.9% in Annovis Bio (ANVS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Modelo maker Constellation Brands is primed for market share gains but we still see one issue with the company https://www.cnbc.com/2024/04/07/modelo-maker-constellation-brands-is-primed-for-market-share-gains.html Apr 07, 2024 - Constellation Brands is positioned for market share gains with a strong business outlook despite this one overhang.
U.S. Weekly FundFlows Insight Report: Led By International Multi-Cap And Japanese Funds, International ETFs See 15th Straight Weekly Inflow https://seekingalpha.com/article/4682557-us-weekly-fundflows-insight-report-led-by-international-multi-cap-and-japanese-funds-international-etfs-15th-straight-weekly-inflow?source=feed_tag_etf_portfolio_strategy Apr 07, 2024 - At close of LSEG Lipper’s fund-flows week, US broad-based equity indices reported negative returns, marking only the third weekly loss in the past 11. Read more here.
Gold hits another all-time high; strategist sees price headed to $3,000 https://seekingalpha.com/news/4087707-gold-hits-another-all-time-high-strategist-sees-price-headed-to-3000?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news Apr 05, 2024 - Gold prices reached a record high for the 13th time this year, driven by geopolitical tensions, interest rate cut expectations, and central bank buying.
S&P 500 sees worst week of 2024 as strong labor market data dents rate cut hopes https://seekingalpha.com/news/4087704-sp-500-sees-worst-week-of-2024-as-strong-labor-market-data-dents-rate-cut-hopes?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news Apr 05, 2024 - The S&P 500 (SP500) on Friday retreated 0.95% for the week to end at 5,204.34 points, posting losses in three out of five sessions
Kura Sushi USA sees positive impact from new rewards program https://www.nrn.com/casual-dining/kura-sushi-usa-sees-positive-impact-new-rewards-program Apr 05, 2024 - The revolving bar model also adds DoorDash as third-party delivery platform
HSBC upgrades UnitedHealth to hold, sees risks priced in https://seekingalpha.com/news/4087375-hsbc-upgrades-unitedhealth-to-hold-sees-risks-priced-in?source=feed_sector_healthcare Apr 04, 2024 - HSBC has upgraded UnitedHealth Group (UNH) to hold from reduce, stating that it sees many of the current risks facing the company already baked into the price. Read more here.
Think Amazon Stock Has Peaked? Here's 1 Chart That Every Investor Needs to See. https://www.fool.com/investing/2024/04/04/think-amazon-stock-has-peaked-heres-1-chart-that/?source=iedfolrf0000001 Apr 04, 2024 - This has been the best way to predict Amazon's stock price in the past.
Wall Street Analysts See GE HealthCare (GEHC) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2250422/wall-street-analysts-see-ge-healthcare-gehc-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2250422 Apr 04, 2024 - Based on the average brokerage recommendation (ABR), GE HealthCare (GEHC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Pages: 123456789...29

<<<Page 4>